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Background: 
Recent studies indicate that reactive oxygen species (ROS) are involved in persistent pain, including 
neuropathic and inflammatory pain. Since the data suggest that ROS are involved in central sensitization, the 
present study examines the levels of activated N-methyl-D-aspartate (NMDA) receptors in the dorsal horn after 
an exogenous supply of three antioxidants in rats with chronic post-ischemia pain (CPIP). This serves as an 
animal model of complex regional pain syndrome type-I induced by hindpaw ischemia/reperfusion injury.
Methods:
The application of tight-fitting O-rings for a period of three hours produced CPIP in male Sprague-Dawley 
rats. Allopurinol 4 mg/kg, allopurinol 40 mg/kg, superoxide dismutase (SOD) 4,000 U/kg, N-nitro-L-arginine 
m e t h y l  e s t e r  ( L - N A M E )  1 0  m g / k g  a n d  S O D  4 , 0 0 0  U / k g  p l u s  L - N A M E  1 0  m g / k g  w e r e  a d m i n i s t e r e d  i n t r a -
peritoneally just after O-ring application and on the first and second days after reperfusion. Mechanical 
allodynia was measured, and activation of the NMDA receptor subunit 1 (pNR1) of the lumbar spinal cord 
(L4-L6) was analyzed by the Western blot three days after reperfusion.
Results:
Allopurinol reduced mechanical allodynia and attenuated the enhancement of spinal pNR1 expression in 
CPIP rats. SOD and L-NAME also blocked spinal pNR1 in accordance with the reduced mechanical allodynia 
in rats with CPIP .
Conclusions:
The present data suggest the contribution of superoxide, produced via xanthine oxidase, and the participation 
of superoxide and nitric oxide as a precursor of peroxynitrite in NMDA mediated central sensitization. Finally, 
the findings support a therapeutic potential for the manipulation of superoxide and nitric oxide in ischemia/ 
reperfusion related pain conditions. (Korean  J  Pain  2010;  23:  1-10)
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INTRODUCTION
　　Complex regional pain syndrome (CRPS) is the disease 
appearing after tissue injury or nerve injury, such as trau-
ma, fracture, and burn, and causing neuropathic pain, im-
pairment of the autonomic nervous system and of motor 
function. Reactive oxygen species (ROS), secretion of cy-
tokine, immunological and inflammatory responses, ab-
normal  responses  of  the  autonomic  nerve  system,  and 
changes in the central nervous system have been sug-
gested as the cause of CRPS, but the detailed mechanism 
has not yet been clarified [1].
　　Recently, Coderre et al. [2] reported a chronic post- 
ischemia pain (CPIP) model as the necessary model to in-
vestigate the pathophysiology of CRPS. This model, which 
is to induce four weeks of allodynia and hyperalgesia by 
causing ischemia/reperfusion (IR) injury on the hindpaw of 
a rat, has a similar pain pattern to that of ischemic in-
jury-related  CRPS  caused  after  fractures,  arthroscopic 
surgery, and overly tight casting. Coderre et al. [2] re-
ported that ROS is correlated with the generation of allo-
dynia by decreasing allodynia with the ROS scavenger in 
this model. In addition, Kwak et al. [3] showed the role of 
a more characteristic ROS, such as superoxide and nitric 
oxide (NO), on the generation of postischemic allodynia by 
using several drugs to block free-radical reaction path-
ways in a CPIP model. These results correspond with the 
results from the conventional animal pain model. In other 
words, in the peripheral nerve injury (spinal nerve ligation) 
model, it was reported that free radical scavengers, such 
as phenyl-N-t-butyl nitrone (PBN) and 5,5-dimethyl-1- 
pyrroline-N-oxide (DMPO), decrease mechanical allodynia 
[4],  and  a  systemically  or  intrathecally  injected  anti-
oxidants reduce the formalin-induced nociceptive response 
in the hindpaws of mice [5]. In addition, after peripheral 
n e r v e  i n j u r y  ( s c i a t i c  n e r v e  t r a n s a c t i o n ,  S N T ) ,  t h e  R O S  
generation in the spinal cord increases while the SOD ac-
tivity decreases [6], and the mitochondrial ROS inside the 
spinal dorsal horn neurons increases in the spinal nerve 
ligation model [7]. These results show the important role 
of the ROS, increased inside the spinal cord or peripheral 
tissue, in gener ating and m ain taining c hr on ic persisten t 
pain after nerve injury, inflammatory, or ischemic injury.
　　I n  t h i s  r e s e a r c h ,  b y  m e a n s  o f  a  n e u r o p a t h i c  p a i n  
model and an inflammatory pain model, the enhancement 
of  N-methyl-D-aspartate  (NMDA)  receptor  phosphor-
y l a t i o n  b y  R O S  h a s  d r a w n  a t t e n t i o n  a s  a n  i m p o r t a n t  
mechanism of central sensitization [8-11]. From this, it is 
suggested that the development of the allodynia mecha-
nism, expressed in the CPIP model, may result in the in-
creased ROS in spinal cord or peripheral tissue enhances 
NMDA receptor phosphorylation to induce central sensiti-
zation.
　　Therefore, in this study, we have performed two ani-
mal experiments to examine whether the increased ROS 
is involved in central sensitization through NMDA receptor 
phosphorylation in CPIP model. First, in order to inves-
tigate the role of superoxide produced by xanthine oxidase 
(XO), which has drawn attention as a main ROS that caus-
es post-IR injury tissue damage in the CPIP model, the 
d e g r e e  o f  N M D A  r e c e p t o r  p h o s p h o r y l a t i o n  i n  t h e  s p i n a l 
cord was measured in the rats, which were given allopur-
inol (an XO inhibitor) to examine the involvement of super-
oxide mediated by XO in central sensitization by NMDA re-
ceptor phosphorylation. Second, in order to clarify the role 
of superoxide and nitric oxide, which produce peroxynitrite 
(known to have strong post-IR injury pro-inflammatory 
a c t i o n  a n d  c y t o t o x i c i t y ) ,  w e  h a v e  u s e d  s u p e r o x i d e  d i s-
mutase  (SOD),  which  dismutates  superoxide  and  N-ni-
tro-L-arginine methyl ester (L-NAME) (a NO synthase in-
hibitor), to investigate whether superoxide and NO are in-
volved in the phosphorylation of NMDA receptor and the 
expression of allodynia that is related with post-ischemia 
injury.
MATERIALS  AND  METHODS
　　All the housing conditions and experimental proce-
dures were approved by the Institutional Animal Care and 
Use Committee and were in accordance with the National 
I n s t i t u t e s  o f  H e a l t h  g u i d e l i n e s  o n  l a b o r a t o r y  a n i m a l  
welfare.
　　Male Sprague-Dawley rats (280-320 g) were housed 
in the animal room, w here tem perature, humidity, ligh t, 
and  noise  were  automatically  maintained,  and  they  re-
ceived water and food ad libitum. They were placed in the 
animal room for three days prior to the experiment in order 
to adjust to the environment.
　　The CPIP model induced by hindpaw IR injury (created 
by Coderre et al.) [2] was applied to the animals for the 
experiment. After the rats were anesthetized with sodium 
pentobarbital, a 7/32 inch of Nitrile 70 Durometer O-ring TH Ryu, et al / Superoxide and NO in Central Sensitization 3
(O ring West, Seattle, USA) was placed at the rat's left 
hindpaw just proximal to the ankle joint for three hours 
to induce ischemia and then the O-ring was removed for 
reperfusion. The location of the O-ring was standardized 
as the area near to the medial malleolus. For the sham 
group (n = 4), the sham operation that did not induce is-
chemia at the hindpaw was performed by cutting one side 
of the O-ring.
　　The experimental group was divided into small groups 
in which allopurinol 4 mg/kg (LA Group, n = 4), allopurinol 
40 mg/kg (HA Group, n = 4), superoxide dismutase 4,000 
U/kg (SOD Group, n = 4), N-nitro-L-arginine methyl ester 
10 mg/kg (L-NAME Group, n = 4), and SOD 4,000 U/kg 
and L-NAME 10 mg/kg (SOD ＋ L-NAME Group, n = 4) 
were  intraperitoneally  injected  respectively,  immediately 
after the O-ring placement, one day after reperfusion and 
two days after reperfusion. All the chemicals were from 
Sigma Chemical Co. (St. Louis, MO) and resolved in normal 
saline just before the injection. For the vehicle group, the 
same amount of normal saline (500 μl) was injected.
　　The high dose of allopurinol 40 mg/kg used in the ex-
periment was decided based on the amount used in the 
previous studies related to IR injury [12-15] and one tenth 
of it was decided as the low dose; 50 mg/kg allopurinol 
for rats is one third of the dose for humans in mg/m
2 basis 
[ 1 6 ] .  T h e  d o s e  o f  L - N A M E  a n d  S O D  w e r e  a l s o  d e c i d e d 
based on the conventional research articles related to neu-
ropathic pain model and IR injury [17,18].
　　Behavioral tests were blindly performed by the tester, 
w h o  w a s  g i v e n  n o  i n f o r m a t i o n  a b o u t  t h e  e x p e r i m e n t a l  
treatment on the rats. In order to observe the behaviors, 
the rats were placed in a transparent acryl box installed 
on a wire net. After 15 minutes of adaptation time, the 
mechanical allodynia was observed.
　　Dynamic  plantar  aesthesiometer  (DPA,  Ugo  Basile, 
Comerio, Italy), operated in an automated von Frey meth-
od, was used for the measurement of mechanical allodynia. 
After  the  animals  for  the  experiment  were  completely 
adapted to the wire net, von Frey filament (straight metal 
filament, 0.5 mm diameter) was placed at the plantar sur-
face of the ipsilateral hindpaw and the force (Max. 50 g) 
was increased gradually until withdrawal response, in order 
t o  m e a s u r e  t h e  f o r c e  n e e d e d  t o  c a u s e  t h e  w i t h d r a w a l  
response. The force was applied for four times with a min-
imum 10 second interval in order to measure the paw with-
drawal threshold. The mechanical allodynia was examined 
a n d  t h e a v e r a ge  t hr e s h o l d  w a s  c a l c u l a t ed  f o r  t h e  c o n-
tralateral hindpaw in the same manner. The measurement 
data before the IR injury was set as the baseline value and 
the ipsilateral and contralateral data were measured on the 
third day after reperfusion when mechanical allodynia was 
the maximum [3].
　　After the mechanical allodynia was measured on the 
third day from reperfusion, the L4-6 spinal cord was ex-
tracted by lumbar laminectomy, separated into left (ipsila-
t e r a l )  a n d  r i g h t  ( c o n t r a l a t e r a l )  c o r d ,  i m m e d i a t e l y  f r o z e n 
with liquid nitrogen, and then dissolved in the dissolving 
buffer solution (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 
mM EDTA, 2 mM Na3Vo4, 0.5 mM DTT, 10% Glycerol, 1% 
Nonidet  P-40,  protease  inhibitor  cocktail).  After  cen-
trifugation  (12,000  rpm,  4
oC,  20  minutes),  the  super-
natants were separated and the proteins were quantified 
b y  t h e  B r a d f o r d  m e t h o d  ( B i o - R a d ,  H e r c u l e s ,  U S A ) .  T h e 
amount of 50 μg of the whole extracted proteins was mixed 
with the buffer solution, including a gel loading buffer (0.5 
M Tris-HCl, glycerol, 10% SDS, 0.5% bromophenol blue). 
It was boiled for five minutes at 100
oC and moved to the 
nitrocellulose membrane after 10% SDS-polyacrylamide gel 
electrophoresis. The membrane reacted with tris buffered 
saline (50 mM Tris pH 7.4, 10 mM NaCl), including 3% skim 
milk, for one hour at room temperature (15-30
oC) and then 
reacted with a phosphorylated NMDA-receptor subunit 1 
(pNR1)  and  antibody  (Upstate  biotechnology,  Temecula, 
USA) at 4
oC overnight.
　　The membrane was washed with tris buffered saline 
(50 mM Tris pH 7.4, 10 mM NaCl) and reacted with a mon-
oclonal secondary antibody conjugated with peroxidase di-
luted at the ratio of 1：2,000 for one hour at room tem-
perature (15-30
oC) to identify the proteins with the ECL 
system (Amersham Biosciences, Buckinghamshire, England).
　　The measured data was indicated as the mean ± SEM 
and analyzed by a paired t-test and analysis of variance 
(ANOV A) with an SPSS 12.0 program. The post-hoc test 
was performed with T ukey's HSD method.
RESULTS
1. Hindpaw mechanical allodynia
　　The pre-IR mechanical withdrawal threshold (baseline) 
measured at contralateral hindpaw and ipsilateral hindpaw 
had no significant difference between the groups. Although 
there was no difference with the baseline in the mechanical 4 Korean J Pain Vol. 23, No. 1, 2010
Fig. 1. The mechanical thresholds in the ipsilateral (A) and contralateral (B) hindpaws are measured on 1 hour before ischemia 
(baseline) and 3 days after reperfusion (3 days). The data are presented as average ± SEM. Sham: non invasive sham
control, Vehicle: normal saline i.p., LA: allopurinol 4 mg/kg i.p., HA: allopurinol 40 mg/kg i.p., *P ＜ 0.05 compared with
sham group, 
†P  ＜ 0.05 compared with vehicle group, 
‡P ＜ 0.05 compared with LA group.
Fig. 2. The mechanical thresholds in the ipsilateral (A) and contralateral (B) hindpaws are measured on 1 hour before ischemia 
(baseline) and 3 days after reperfusion (3 days). The data are presented as average ± SEM. Sham: non invasive sham
control, Vehicle: normal saline i.p., SOD: superoxide dismutase (SOD) 4,000 U/kg i.p., L-NAME: N-nitro-L-arginine methyl 
ester 10 mg/kg i.p., SOD ＋ L-NAME: SOD 4,000 U/kg plus L-NAME 10 mg/kg i.p., *P ＜ 0.05 compared with sham 
group, 
†P ＜ 0.05 compared with vehicle group, 
‡P ＜ 0.05 compared with SOD group, 
§P ＜ 0.05 compared with L-NAME
group.
withdrawal threshold measured in the sham group on the 
third day after reperfusion, the vehicle group showed sig-
nificant decrease from the baseline, and the measurement 
at the ipsilateral hindpaw showed an even lower mechan-
i c a l  w i t h d r a w a l  t h r e s h o l d  t h a n  t h a t  o f  t h e  c o n t r a l a t e r a l  
hindpaw (paired T-test, P ＜ 0.05, Fig. 1).
　　When compared to the vehicle group, the LA group and 
HA group on the third day after reperfusion showed sig-
nificant increase in the ipsilateral mechanical withdrawal 
threshold (F3,12 = 10,984.1, P ＜ 0.05, Fig. 1A), as well as 
the contralateral mechanical withdrawal threshold (F3,12 = 
13,519.6, P ＜ 0.05, Fig. 1B). The HA group had a more 
significant increase than the LA group regarding the ipsi-
lateral mechanical withdrawal threshold (F3,12 = 10,984.1, P 
＜ 0.05, Fig. 1A), as well as the contralateral mechanical 
withdrawal threshold (F3,12 = 13,519.6, P ＜ 0.05, Fig. 1B).
　　When compared to the vehicle group, the ipsilateral 
m e c h a n i c a l  w i t h d r a w a l  t h r e s h o l d  o f  t h e  S O D  g r o u p ,  
L-NAME group, and SOD ＋ L-NAME group on the third 
day  after  reperfusion  had  significant  increase  (F4,15 =  TH Ryu, et al / Superoxide and NO in Central Sensitization 5
Fig. 3. The average gel density ratio of pNR1 and β-actin in ipsilateral spinal cord (A) and contralateral spinal cord (B) 
and an example of Western blot gel (bottom). The data are presented as average ± SEM. Sham: non invasive sham control,
Vehicle: normal saline i.p., LA: allopurinol 4 mg/kg i.p., HA: allopurinol 40 mg/kg i.p., *P ＜ 0.05 compared with sham group,
†P ＜ 0.05 compared with vehicle group, 
‡P  ＜ 0.05 compared with LA group.
8,414.5, P ＜ 0.05, Fig. 2A), as well as the contralateral 
mechanical  withdrawal  threshold  (F4,15  =  8,406.0,  P  ＜ 
0.05, Fig. 2B). The ipsilateral mechanical withdrawal thre-
shold of the SOD ＋ L-NAME group on the third day after 
reperfusion had significant increase when compared to the 
SOD group and L-NAME group, and the ipsilateral me-
chanical withdra wal threshold of the SO D group showed 
significant increase compared to the L-NAME group (F4,15 
= 8,414.5, P ＜ 0.05, Fig. 2A).
　　The contralateral mechanical withdrawal threshold of 
the SOD ＋ L-NAME group and SOD group on the third 
day  after  reperfusion  showed  significant  increase  when 
c o m p a r e d  t o  t h e L- N A M E  gr o u p  (F 4,15 =  8 ,4 0 6 .0 ,  P ＜ 
0.05, Fig. 2B), while there was no significant difference 
between the SOD ＋ L-NAME group and SOD group.
2. Measurement of phosphorylated NMDA-receptor sub-
unit 1 (pNR1)
　　The ipsilateral and contralateral spinal cord pNR1 of 
the vehicle group showed significant increase when com-
pared with the psilateral and contralateral spinal cord pNR1 
of the sham group, respectively. When compared to the 
vehicle group, the ipsilateral spinal cord pNR1 of the LA 
group and HA group showed significant decrease (F3,12 = 
699.8, P ＜ 0.05, Fig. 3A), as well as the contralateral spi-
nal cord pNR1 (F3,12 = 1045.7, P ＜ 0.05, Fig. 3B). The ipsi-
lateral pNR1 of the HA group decreased significantly com-
pared to the LA group (F3,12 = 699.8, P ＜ 0.05, Fig. 3A), 
as well as the contralateral pNR1 compared to the LA group 
(F3,12 = 1,045.7, P ＜ 0.05, Fig. 3B).
　　The  ipsilateral  spinal  cord  pNR1  of  the  SOD  ＋ 
L-NAME group showed significant decrease with that of 
the SOD group and L-NAME group, while the ipsilateral 
spinal cord pNR1 of SOD group showed significant increase 
compared to the L-NAME group (F2,9 = 635.7, P ＜ 0.05, 
Fig. 4A). The contralateral pNR1 of the SOD ＋ L-NAME 
group  and  SOD  group  showed  significant  decrease  with 
that of the L-NAME group (F2,9 = 1,209.1, P ＜ 0.05, Fig. 
4B), but no significant difference in contralateral pNR1 was 
found between the SOD ＋ L-NAME group and SOD group.
DISCUSSION
　　The  main  findings  of  this  study  are  as  followings: 
First, in the CPIP model where mechanical allodynia was 
developed by rat hindpaw IR injury, allopurinol significantly 
decreased  the  ipsilateral  and  contralateral  spinal  cord 
p N R 1 .  T h i s  s u g g e s t s  t h a t  t h e  s u p e r o x i d e  m e d i a t e d  b y  
post-IR injury XO may cause ipsilateral and contralateral 
allodynia by inducing NMDA receptor phosphorylation in 
spinal cord cells. Second, SOD and L-NAME, which block 
generation of superoxide and NO, also decreased ipsilateral 6 Korean J Pain Vol. 23, No. 1, 2010
Fig. 4. The average gel density ratio of pNR1 and β-actin in ipsilateral spinal cord (A) and contralateral spinal cord (B) 
and an example of Western blot gel (bottom). The data are presented as average ± SEM. Sham: non invasive sham control,
Vehicle: normal saline i.p., SOD: superoxide dismutase (SOD) 4,000 U/kg i.p., L-NAME: N-nitro-L-arginine methyl ester 10
mg/kg i.p., SOD ＋ L-NAME: SOD 4,000 U/kg plus L-NAME 10 mg/kg i.p., *P ＜ 0.05 compared with sham group, 
†P
＜ 0.05 compared with vehicle group, 
‡P < 0.05 compared with SOD group, 
§P ＜ 0.05 compared with L-NAME group.
and contralateral spinal cord pNR1. This shows that in-
creased superoxide and NO are important ROS in causing 
ipsilateral  and  contralateral  allodynia,  as  they  enhance 
NMDA receptor phosphorylation in the spinal cord to in-
duce central sensitization.
　　ROS are involved in an intracellular signal transduction 
pathway, as the normal derivatives of oxygen metabolism. 
They are balanced by the antioxidant capacity in the body, 
but when the balance is lost, ROS rapidly increases and 
causes oxidative stress. Particularly, during ischemia, hy-
poxanthine is accumulated by ATP depletion, and super-
oxide and hydrogen peroxide are generated in the process 
of hypoxanthine oxidation by XO during reperfusion [19]. 
Superoxide acts as a proinflammatory by increasing endo-
thelial permeability, generating chemotactic factors, such 
as leukotriene B4, and inducing neutrophil [20,21]. React-
i n g  w i t h  N O ,  s u p e r o x i d e  f o r m s  p e r o x y n i t r i t e ,  w h i c h  h a s 
strong cytotoxicity and acts as a pro-inflammatory sub-
stance. Peroxynitrite is involved in post-ischemia cellular 
injury by continuously generating superoxide, inactivating 
intrinsic MnSOD by means of nitration [22]. Clarifying the 
pain-related role of ROS involved in such IR injury, Kim 
et al. [23] revealed that plasma superoxide mediated by XO 
was blocked with a high dose of allopurinol before ischemia 
in the CPIP model; furthermore, Kwak et al. [3] reported 
that allodynia was reduced as a superoxide and NO was 
selectively blocked in the CPIP model. Khalil and Khodr [24] 
reported that the activity of XO, which catalyzes super-
oxide  generation,  significantly  increased  in  the  sciatic 
nerve of the CCI model rats and the thermal threshold was 
decreased. These results suggest that ROS is related to 
t h e  i n c r e a s e  o f  n o c i c e p t o r  s e n s i t i v i t y ,  a s  w e l l  a s  p a i n  
transmission pathway and mechanism, and may serve as 
the proofs that show the action of ROS in peripheral tissue 
on chronic pain.
　　The development and maintenance of chronic pain is 
known to be related with central sensitization. Superoxide 
and NO have drawn attention as the ROS mainly involved 
in central sensitization, and the role of superoxide in rela-
tion with mitochondrial MnSOD has been focused. Park et 
al. [7] reported that mitochondrial ROS increased in the 
spinal dorsal horn of the spinal nerve ligation model. Wang 
et al. [25] reported that intraplantar injection of carra-
geenan in rats caused hyperalgesia and increased MnSOD 
nitration in the spinal cord, and M40403, the SOD analog, 
decreased hyperalgesia and MnSOD nitration. Schwartz et 
al. [26] measured mitochondrial superoxide of the spinal 
dorsal horn in the inflammatory pain model rats (capsaicin 
induced secondary hyperalgesia) and reported that the in-
creased superoxide was important in the sensory process-TH Ryu, et al / Superoxide and NO in Central Sensitization 7
ing of hyperalgesia in the spinal cord and maintained by 
MnSOD nitration. Alternatively, Xu et al. [27] reported that 
NO,  as  a  retrograde  messenger,  released  glutamate 
through  the  presynaptic  cGMP-PKG  pathway  and  in-
creased the neuronal NO synthase (nNOS) activity; then 
NO  itself  increased  NO  generation  to  neuropathic  pain 
along  with  continued  afferent  stimuli.  After  peripheral 
nerve injury, release of excitatory amino acids, inclunging 
glutamate, in the dorsal horn stimulates NMDA receptor; 
then superoxide and NO are produced by activation of en-
zymatic cascades through NMDA receptor. MnSOD nitra-
tion  by  peroxinitrite,  reactants  of  superoxide  and  NO, 
maintain high level of superoxide, then spinal cord hyper-
sensitivity and central sensitization mediated by NMDA are 
increased [8,28].
　　Physiologically, spinal cord central sensitization is de-
fined as the increased reactivity of the spinal dorsal horn 
to the peripheral nociceptor stimuli [29], and induction of 
the spinal cord central sensitization is well known to be 
related with NMDA receptor activity. The NMDA receptor 
is a complex, and five NMDA receptor subtypes have pre-
viously  been  categorized.  Among  them,  NMDA  receptor 
subtype 1 is the subtype that constitutes functional re-
ceptor channel complex and plays the original function of 
the NMDA receptor. The NMDA receptor is activated by 
phosphorylation  of  NMDA  receptor  subtype  1  [30,31].  In 
spinothalamic tract of the inflammatory pain model, pNR1 
is increased by the intradermal injection of capsaicin [9]. 
In the inflammatory pain model, injection of NMDA induced 
by formalin increases pain behavior, and the NMDA re-
ceptor antagonist decreases hyperalgesia [10]. Gao et al. 
[8,11]  reported  that  pNR1  immunoreactive  neurons  in-
creased in the spinal dorsal horn of rats with nerve injury, 
and the decrease of pNR1 immunoreactive neurons in the 
spinal dorsal horn is consistent with the decrease of hy-
peralgesia after the injection of PBN, which was the anti-
oxidant in the neuropathic pain model and inflammatory 
pain model. They thus concluded that ROS is involved in 
the central sensitization through NMDA receptor activa-
tion.
　　In this study, the result that pNR1 was decreased by 
blocking the superoxide mediated by XO, as well as the su-
peroxide and NO (the precursors of peroxynitrite), showed 
that ROS is involved in the central sensitization mechanism 
related with the NMDA receptor in this IR injury model, as 
in the previous reports based on the inflammatory pain 
model and neuropathic pain model [8-11], and central sen-
sitization that contributes to continued neuropathic pain, 
such as mechanical allodynia, can be reduced by blocking 
superoxide and NO. However, NO is the type of molecule 
that can have dual effects depending on its concentration, 
NOS isoform, and redox balance, etc [32,33]. As contrast-
ing research results show that NO is the molecule acting 
on the development of neuropathic pain, No has been re-
ported to be involved in analgesia. With respect to this, 
there are reports that the L-arginine-NO pathway was in-
volved in peripheral and central analgesia [34], NO reduced 
hyperalgesia by carrageenan, and NO donor, such as ni-
troglycerine, reduced hyperalgesia [34,35]. In addition, the 
L - a r g i n i n e - N O - c G M P  p a t h w a y  w a s  r e p o r t e d  t o  b e  i n-
volved with analgesia of morphine, clonidine, codeine, ket-
amine, and gabapentin, etc [34-41]. Furthermore, Xanthos 
et al. [42] reported that the NOS inhibitor and NO donor 
injected on the second day after reperfusion in the CPIP 
model  relieved  vasoconstriction  and  ischemia,  and  thus, 
reduced the pain. Therefore, in the post-IR injury animal 
pain model of this study, blocking NO, which is the pre-
cursor of peroxynitrite, can contribute to pain development 
b y  r e d u c i n g  p e r i p h e r a l  a n d  c e n t r a l  s e n s i t i z a t i o n  a n d / o r  
cancel the vasoconstriction and ischemia-relieving effect 
of NO through an alpha receptor. In particular, blocking 
a superoxide was more effective than blocking NO in re-
ducing the expression of mechanical allodynia and central 
sensitization, which is assumed to be the possible action 
of NO which has such dual effects.
　　O f  t h e  C R P S - I  p a t i e n t s ,  1 0 %  s h o w e d  m i r r o r  i m a g e 
pain, which is diffused to other limbs that are not injured 
[43], and allodynia and hyperalgesia were also found in a 
contralateral part in the CPIP model [2,3,23]. Mirror image 
pain is found not only in the CPIP model, but also in the 
neuropathic pain model and inflammatory pain model, and 
such theories as central mechanism and humoral mecha-
nism have been postulated. One suggested opinion is that 
activation of a glial cell in the spinal cord and the discharge 
of cytokine may cause the distant or mirror image pain 
[44,45], and Gordh and Sharma reported that structural 
change was observed in the contralateral spinal cord two 
weeks after the nerve injury and continued for eight weeks 
[46].  Since  sensory  response  in  the  peripheral  afferent 
nerve is not directly projected to the contralateral spinal 
dorsal horn [47], the contralateral sensitization in the spi-
nal cord is assumed to be caused by commissural inter-8 Korean J Pain Vol. 23, No. 1, 2010
neurons [48,49]. In the recent study of Kwak et al. [50], 
the mirror image pain in the CPIP model was reportedly 
due to central sensitization related to the activation of the 
NMD A receptor; and through this study, the mechanical 
allodynia  by  such  contralateral  central  sensitization  was 
confirmed to be caused by ROS.
　　The two possibilities that must be considered are that 
the ROS scavenger, which was intraperitoneally injected 
before and after the IR injury, when mechanical allodynia 
was generated, may have reduced the afferent stimuli that 
cause central sensitization and thus central sensitization 
in spinal cord, or reduced sensitization of the spinal cord 
through direct blocking of superoxide and NO in the spinal 
dorsal horn cell. However, the exact part of the action 
could not be determined. Thus, various approaches, in-
cluding intrathecal drug injection, should be used in the 
study to clarify the exact action parts of the pain mecha-
nism where ROS acts in the post-IR injury animal pain 
model.
　　I n  c o n c l u s i o n ,  s u p e r o x i d e  b y  x a n t h i n e  o x i d a s e ,  a n d 
superoxide and NO, which are the precursors of peroxyni-
trite, are assumed to be involved in central sensitization 
related  to  NMDA  receptor  phosphorylation  in  the  CPIP 
model and contribute in causing and maintaining mechan-
ical allodynia.
　　T h e s e  r e s u l t s  s u g g e s t  t h e  p o s s i b i l i t y  o f  u s i n g  R O S 
scavengers, such as SOD and L-NAME blocking superoxide 
and NO, which are the precursors of allopurinol and perox-
ynitrite, as effective therapeutics for patients of chronic 
pain related to ischemic injury.
REFERENCES
1. Jänig  W,  Baron  R.  Complex  regional  pain  syndrome  is  a 
disease of the central nervous system. Clin Auton Res 2002; 
12: 150-64.
2 . C o d e r r e  T J ,  X a n t h o s  D N ,  F r a n c i s  L ,  B e n n e t t  G J .  C h r o n i c  
post-ischemia pain (CPIP): a novel animal model of complex 
regional pain syndrome-type I (CRPS-I; reflex sympathetic 
dystrophy)  produced  by prolonged hindpaw  ischemia  and 
reperfusion in the rat. Pain 2004; 112: 94-105.
3. Kwak KH, Han CG, Lee SH, Jeon Y, Park SS, Kim SO, et 
a l .  R e a c t i v e  o x y g e n  s p e c i e s  i n  r a t s  w i t h  c h r o n i c  p o s t -  
ischemia pain. Acta Anaesthesiol Scand 2009; 53: 648-56.
4. Kim HK, Park SK, Zhou JL, T aglialatela G, Chung K, Cog-
geshall RE, et al. Reactive oxygen species (ROS) play an 
important role in a rat model of neuropathic pain. Pain 2004; 
111: 116-24.
5. Ha ci mu ft uog l u  A,  Ha nd y  CR,  Goet t l  VM,  L i n CG,  Da ne  S,  
Stephens  RL  Jr.  Antioxidants  attenuate  multiple  phases  of 
formalin induced nociceptive response in mice. Behav Brain 
Res 2006; 173: 211-6.
6. Guedes RP, Bosco LD, T eixeir a CM, Ar aújo AS, Llesuy S, 
Belló- K l e i n  A ,  e t  a l .  N e u r o p a t h i c  p a i n  m o d i f i e s  a n t i o x i d a n t  
activity in rat spinal cord. Neurochem Res 2006; 31: 603-9.
7. Park ES, Gao X, Chung JM, Chung K. Levels of mitochondrial 
reactive oxygen species increase in rat neuropathic spinal 
dorsal horn neurons. Neurosci Lett 2006; 391: 108-11.
8 . G a o  X ,  K i m  H K ,  C h u n g  J M ,  C h u n g  K .  R e a c t i v e  o x y g e n  
species  (ROS)  are  involved  in  enhancement  of  NMDA- 
receptor  phosphorylation  in  animal  models  of  pain.  Pain 
2007; 131: 262-71.
9. Zou X, Lin Q, Willis WD. Enhanced phosphorylation of NMDA 
receptor 1 subunits in spinal cord dorsal horn and spino-
thalamic tract neurons after intradermal injection of capsaicin 
in rats. J Neurosci 2000; 20: 6989-97.
10. Coderre TJ, Melzack R. The contribution of excitatory amino 
acids to central sensitization and persistent nociception after 
formalin-induced tissue injury. J Neurosci 1992; 12: 3665- 
70.
11. Gao X, Kim HK, Chung JM, Chung K. Enhancement of NMDA 
receptor  phosphorylation  of  the  spinal  dorsal  horn  and 
nucleus  gracilis  neurons  in  neuropathic  rats.  Pain  2005; 
116: 62-72.
1 2 . T r i p a t a r a  P ,  P a t e l  N S ,  W e b b  A ,  R a t h o d  K ,  L e c o m t e  F M ,  
Mazzon E, et al. Nitrite-derived nitric oxide protects the rat 
kidney against ischemia/reperfusion injury in vivo: role for 
xanthine  oxidoreductase.  J  Am  Soc  Nephrol  2007;  18: 
570-80.
13. Radovic M, Miloradovic Z, Popovic T, Mihailovic-Stanojevic 
N, Jovovic D, Tomovic M, et al. Allopurinol and enalapril failed 
to conserve urinary NOx and sodium in ischemic acute renal 
failure  in  spontaneously  hypertensive  rats.  Am  J  Nephrol 
2006; 26: 388-99.
14. Lee WY, Lee SM. Synergistic protective effect of ischemic 
preconditioning and allopurinol on ischemia/reperfusion injury 
in  rat  liver.  Biochem  Biophys  Res  Commun  2006;  349: 
1087-93.
15. Nemeth N, Lesznyak T, Szokoly M, Furka I, Miko I. Allopurinol 
prevents  erythrocyte  deformability  impairing  but  not  the 
hematological  alterations  after  limb  ischemia  reperfusion  in 
rats. J Invest Surg 2006; 19: 47-56.
16. Albuquerque  RG,  Sanson  AJ,  Malangoni  MA.  Allopurinol 
protects enterocytes from hypoxia-induced apoptosis in vivo. 
J Trauma 2002; 53: 415-20.
17. Levy D, Zochodne DW. Local nitric oxide synthase activity 
in a model of neuropathic pain. Eur J Neurosci 1998; 10: 
1846-55.
1 8 .C a b a n  A ,  O c z k o w i c z  G ,  A b d e l - S a m a d  O ,  C i e r p k a  L .  TH Ryu, et al / Superoxide and NO in Central Sensitization 9
Influence  of  ischemic  preconditioning  and  nitric  oxide  on 
microcirculation and the degree of rat liver injury in the model 
of  ischemia  and  reperfusion.  Transplant  Proc  2006;  38: 
196-8.
19. Halliwell  B,  Gutteridge  JC.  Free  radicals  in  biology  and 
medicine. 4th ed. New York, Oxford University Press. 2007, 
p 22.
20. Salvemini  D,  Riley  DP,  Lennon  PJ,  Wang  ZQ,  Currie  MG, 
M a c a r t h u r  H ,  e t  a l .  P r o t e c t i v e  e f f e c t s  o f  a  s u p e r o x i d e  
dismutase mimetic and peroxynitrite decomposition catalysts 
in  endotoxin-induced  intestinal  damage.  Br  J  Pharmacol 
1999; 127: 685-92.
21. Xia ZF, Hollyoak M, Barrow RE, He F, Muller MJ, Herndon 
D N .  S u p e r o x i d e  d i s m u t a s e  a n d  l e u p e p t i n  p r e v e n t  d e l a y e d  
reperfusion injury in the rat small intestine during burn shock. 
J Burn Care Rehabil 1995; 16: 111-7.
22. Li C, Jackson RM. Reactive species mechanisms of cellular 
hypoxia-reoxygenation  injury.  Am  J  Physiol  Cell  Physiol 
2002; 282: C227-41.
2 3 . K i m  K W ,  H a  M J ,  J u n g  K Y ,  K w a k  K H ,  P a r k  S S ,  L i m  D G .  
Reactive oxygen species and N-methyl-D-aspartate recep-
tor-mediated  central  sensitization  in  hindlimb  ischemia/ 
reperfusion injury-induced neuropathic pain rats. Korean J 
Anesthesiol 2009; 56: 186-94.
24. Khalil Z, Khodr B. A role for free radicals and nitric oxide in 
delayed recovery in aged rats with chronic constriction nerve 
injury. Free Radic Biol Med 2001; 31: 430-9.
2 5 . W a n g  Z Q,  P o r r e c a  F ,  C u z z o c r e a  S ,  Ga l e n  K ,  L i g h t f oo t  R ,  
Masini E, et al. A newly identified role for superoxide in in-
flammatory pain. J Pharmacol Exp Ther 2004; 309: 869- 
78.
26. Schwartz ES, Kim HY, Wang J, Lee I, Klann E, Chung JM, 
et  al. P er sist ent pain is dependent on spinal mitochondrial 
antioxidant levels. J Neurosci 2009; 29: 159-68.
27. Xu L, Mabuchi T, Katano T, Matsumura S, Okuda-Ashitaka 
E, Sakimura K, et al. Nitric oxide (NO) serves as a retrograde 
messenger to activate neuronal NO synthase in the spinal 
cord via NMDA receptors. Nitric Oxide 2007; 17: 18-24.
28. Muscoli C, Mollace V, Wheatley J, Masini E, Ndengele M, 
Wang  ZQ,  et  al.  Superoxide-mediated  nitration  of  spinal 
manganese superoxide dismutase: a novel pathway in N- 
methyl-D-aspartate-mediated  hyperalgesia.  Pain  2004; 
111: 96-103.
29. Woolf CJ. Evidence for a central component of post-injury 
pain hypersensitivity. Nature 1983; 306: 686-8.
3 0 .M a s u  M ,  N a k a j i m a  Y ,  M o r i y o s h i  K ,  I s h i i  T ,  A k a z a w a  C ,  
Nakanashi  S.  Molecular  characterization  of  NMDA  and 
metabotropic glutamate receptors. Ann N Y Acad Sci 1993; 
707: 153-64.
3 1 . M o r i  H ,  M i s h i n a  M .  S t r u c t u r e  a n d  f u n c t i o n  o f  t h e  N M D A  
receptor channel. Neuropharmacology 1995; 34: 1219-37.
32. Guix FX, Uribesalgo I, Coma M, Muñoz FJ. Physiology and 
pathophysiology of nitric oxide in the brain. Prog Neurobiol 
2005; 76: 126-52.
33. Zhang XC, Zhang YQ, Zhao ZQ. Different roles of two nitric 
oxide activated pathways in spinal long-term potentiation of 
C-fiber-evoked field potentials. Neuropharmacology 2006; 
50: 748-54.
3 4 .D u a r t e  I D ,  d o s  S a n t o s  I R ,  L o r e n z e t t i  B B ,  F e r r e i r a  S H .  
A n a l g e s i a  b y  d i r e c t  a n t a g o n i s m  o f  n o c i c e p t o r  s e n s i t i z a t i o n  
involves  the  arginine-nitric  oxide  cGMP  pathway.  Eur  J 
Pharmacol 1992; 217: 225-7.
35. Ferreira SH, Lorenzetti BB, Faccioli LH. Blockade of hyper-
algesia  and  neurogenic  oedema  by  topical  application  of 
nitroglycerin. Eur J Pharmacol 1992; 217: 207-9.
36. Bulutcu F, Dogrul A, Güc MO. The involvement of nitric oxide 
in  the  analgesic  effects  of  ketamine.  Life  Sci  2002;  71: 
841-53.
37. Granados-Soto V, Rufino MO, Gomes Lopes LD, Ferreira SH. 
Evidence  for  the  involvement  of  the  nitric  oxide-cGMP 
pathway in the  antinociception of  morphine in the formalin 
test. Eur J Pharmacol 1997; 340: 177-80.
38. Mixcoatl-Zecuatl  T,  Flores-Murrieta  FJ,  Granados-Soto  V. 
The nitric oxide-cyclic GMP-protein kinase G-K＋ channel 
pathway  participates  in  the  antiallodynic  effect  of  spinal 
gabapentin. Eur J Pharmacol 2006; 531: 87-95.
39. Ortiz MI, Castro-Olguin J, Peña-Samaniego N, Castañeda- 
Hernán d e z  G .  P r o b a b l e  a c t i v a t i o n  o f  t h e  o p i o i d  r e c e p t o r - 
nitric oxide-cyclic GMP-K＋ channels pathway by codeine. 
Pharmacol Biochem Behav 2005; 82: 695-703.
40. Ortiz MI, Granados-Soto V, Castañeda-Hernández G. The 
NO-cGMP-K＋ channel pathway participates in the antino-
ciceptive effect of diclofenac, but not of indomethacin. Phar-
macol Biochem Behav 2003; 76: 187-95.
41. de Moura RS, Rios AA, Santos EJ, Nascimento AB, de Castro 
Resende A, Neto ML, et al. Role of the NO-cGMP pathway 
in the systemic antinociceptive effect of clonidine in rats and 
mice. Pharmacol Biochem Behav 2004; 78: 247-53.
42. Xanthos  DN,  Bennett  GJ,  Coderre  TJ.  Norepinephrine- 
induced nociception and vasoconstrictor hypersensitivity in 
rats  with  chronic  post-ischemia  pain.  Pain  2008;  137: 
640-51.
43. Kim  YC.  Complex  regional  pain  syndrome.  Korean  J  Pain 
2004; 17(Suppl): 104-8.
44. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor 
K, Poole S, et al. Spinal glia and proinflammatory cytokines 
medi at e mi rr or-i mage neur opat hi c pai n i n r at s.  J Neur osci 
2003; 23: 1026-40.
45. Twining CM, Sloane EM, Milligan ED, Chacur M, Martin D, 
Poole S, et al. Peri-sciatic proinflammatory cytokines, reactive 
oxygen  species,  and  complement  induce  mirror-image 
neuropathic pain in rats. Pain 2004; 110: 299-309.
46. Gordh T, Sharma HS. Chronic spinal nerve ligation induces 
microvascular permeability disturbances, astrocytic reaction, 10 Korean J Pain Vol. 23, No. 1, 2010
and structural changes in the rat spinal cord. Acta Neurochir 
Suppl 2006; 96: 335-40.
47. Light AR, Perl ER. Reexamination of the dorsal root projection 
to  the  spinal  dorsal  horn  including  observations  on  the 
differential  termination  of  coarse  and  fine  fibers.  J  Comp 
Neurol 1979; 186: 117-31.
48. Koltzenburg M, Wall PD, McMahon SB. Does the right side 
know what the left is doing? Trends Neurosci 1999; 22: 
122-7.
49. Donaldson LF. Unilateral arthritis: contralateral effects. Trends 
Neurosci 1999; 22: 495-6.
50. Kwak KH, Jung KY, Choi JY, Ryu T, Yeo JS, Park SS, et al. 
Contralateral  allodynia  and  central  change  in  the  chronic 
post-ischemic pain model rats. Korean J Anesthesiol 2009; 
56: 419-24.